Venture Catalysts fully exits TruNativ, notching 12.73x return and 67% IRR on wellness D2C bet
Venture Catalysts has taken a complete exit from Indian nutrition and wellness D2C brand TruNativ, realizing 12.73x (67% IRR) on its June 2021 seed round and 1.34x (18% IRR) on a September 2024 follow-on. TruNativ expanded its portfolio and grew across digital and retail channels.
Venture Catalysts fully exited Indian nutrition and wellness D2C brand TruNativ, realizing 12.73x and 1.34x returns across two rounds. TruNativ has expanded its product portfolio and grown across digital and retail channels in India's wellness sector.
Why this matters
The exit follows 100Unicorns' 11x return exit from TruNativ and the brand's $30M Series B led by OrbiMed, signaling strong investor confidence in the clean-label nutrition play.
Retail-brand signals are accelerating, up 299200% QoQ.